The Effect of Fibrinolysis Inhibitors on the Ellagic Acid Activation of Hageman Factor in the Dog
暂无分享,去创建一个
[1] A. S. Douglas,et al. Studies on the Anticoagulant Action of Aprotinin (“Trasylol”) , 1970, Thrombosis and Haemostasis.
[2] A. Girolami,et al. Ellagic acid induced thromboelastographic changes in the normal individual and in several coagulopathies. , 1969, Haematologica Latina.
[3] G. Müller‐Berghaus,et al. Activation of Hageman factor by ellagic acid and the generalized Shwartzman reaction. , 1969, The American journal of pathology.
[4] R. Sheon,et al. The Demise of John Hageman , 1968 .
[5] A. S. Douglas,et al. In vitro and In vivo Studies with Trasylol, an Anticoagulant and a Fibrinolytic Inhibitor , 1968, British journal of haematology.
[6] M. Hilden,et al. Inhibition of thromboplastic activity by Trasylol. In vitro investigations concerning the mechanism of inhibition. , 2009, Scandinavian journal of haematology.
[7] K. Gautvik,et al. Kinin formation and kininogen depletion in rats after intravenous injection of ellagic acid. , 1967, British journal of pharmacology and chemotherapy.
[8] B. Blombäck,et al. Action of a Proteolytic Enzyme Inhibitor on Blood Coagulation in Vitro , 1967, Thrombosis and Haemostasis.
[9] A. Girolami. The action of ellagic acid on the coagulation mechanism and experimental and clinical bleeding. , 1967, Haematologica Latina.
[10] A. Girolami,et al. Hypercoagulable State Induced in Humans by the Intravenous Administration of Purified Ellagic Acid , 1967, Thrombosis and Haemostasis.
[11] C. J. Amris. Inhibition of fibrinolytic and thromboplastic activity by Trasylol. , 2009, Scandinavian journal of haematology.
[12] P. G. Iatridis,et al. Effects of Ellagic Acid upon the Human Fibrinolytic System , 1966, Thrombosis and Haemostasis.
[13] W. Connor,et al. Myocardial infarction associated with severe factor-XII deficiency. , 1966, Lancet.
[14] H. Glueck,et al. Myocardial infarction in a patient with a hageman (factor XII) defect. , 1966, Annals of internal medicine.
[15] Botti Re. Assessment of the hypercoagulable state and ellagic acid. , 1966 .
[16] A. Girolami,et al. The effect of ellagic acid on coagulation in vivo. , 1966, Blood.
[17] O. Ratnoff,et al. STUDIES ON THE PATHOGENESIS OF THROMBOSIS: AN EXPERIMENTAL "HYPERCOAGULABLE" STATE INDUCED BY THE INTRAVENOUS INJECTION OF ELLAGIC ACID. , 1964, The Journal of laboratory and clinical medicine.
[18] O. Ratnoff,et al. ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID. , 1964, The Journal of laboratory and clinical medicine.
[19] S. G. Iatridis,et al. Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system. , 1962, The Journal of clinical investigation.
[20] S. Niewiarowski,et al. Rôle du Facteur Contact (Facteur Hageman) dans la Fibrinolyse , 1959, Thrombosis and Haemostasis.
[21] E. Cliffton,et al. Fibrinolytic and proteolytic activity of a human plasminogen, prepared from fraction III of human plasma. , 1953, Journal of applied physiology.
[22] Congenital Afihrinogenemia A Case Report with Some Considerations on the Hereditary Transmission of · this Disorder , 2022 .